Sustainable Practices in Medicinal Chemistry Part 2: Green by Design
Overview
Authors
Affiliations
With the development of ever-expanding synthetic methodologies, a medicinal chemist's toolkit continues to swell. However, with finite time and resources as well as a growing understanding of our field's environment impact, it is critical to refine what can be made to what should be made. This review seeks to highlight multiple cheminformatic approaches in drug discovery that can influence and triage design and execution impacting the likelihood of rapidly generating high-value molecules in a more sustainable manner. This strategy gives chemists the tools to design and refine vast libraries, stress "druglikeness", and rapidly identify SAR trends. Project success, i.e., identification of a clinical candidate, is then reached faster with fewer molecules with the farther-reaching ramification of using fewer resources and generating less waste, thereby helping "green" our field.
Martinengo B, Diamanti E, Uliassi E, Bolognesi M ACS Infect Dis. 2024; 10(6):1856-1870.
PMID: 38724015 PMC: 11184551. DOI: 10.1021/acsinfecdis.4c00172.
Feng R, Zhen Y, Wu D, Sun L, Xu J, Li X Sci Adv. 2024; 10(10):eadl0026.
PMID: 38457511 PMC: 10923520. DOI: 10.1126/sciadv.adl0026.
Ahmad B, Keasler K, Stacy E, Meng S, Hicks T, Milner P Chem Mater. 2024; 35(13):4883-4896.
PMID: 38222037 PMC: 10785605. DOI: 10.1021/acs.chemmater.3c00741.
Ji S, Wang Y, Su Z, He D, Du Y, Guo M RSC Adv. 2022; 8(25):13989-13996.
PMID: 35539340 PMC: 9079881. DOI: 10.1039/c8ra01056k.
Mu X, Wang Z, Feng B, Xu L, Gao L, Satheeshkumar R RSC Adv. 2022; 11(6):3216-3220.
PMID: 35424294 PMC: 8694002. DOI: 10.1039/d0ra09247a.